Buy or sell Tilray stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Tilray Stock

Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies, and governments.

About Tilray Stock

Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies and governments. Tilray cultivates and delivers the benefits of medical cannabis safely and reliably. Healthcare practitioners and patients expect and deserve only the best service and products. Accordingly, Tilray provides expedited delivery, prompt follow-up, and consistent quality of each strain they harvest.

Funding History

February 2018	$60.0M

Management

Director

Catherine Jacobson

Founder

Brendan Kennedy

Co-Founder

Christian Groh

Press

Tilray Seeks $100 Million IPO In US Filing

Seeking Alpha - Jun, 27 2018

Canada: Tilray files for US float

International Financing Review - Jun, 25 2018

Canadian cannabis company cultivates IPO

PitchBook News & Analysis - Jun, 22 2018

Tilray files for IPO, after Canada legalizes marijuana

Axios - Jun, 21 2018

Tilray® Launches New High-CBD Cannabis Oil for Patients in Need

- May, 22 2018

Tilray® Launches High Park Company™ to Produce and Distribute Adult-Use Cannabis in Canada

Business Wire (press release) - Apr, 4 2018

Tilray® Forms Strategic Alliance with Leading Pharmaceutical Company in Canada

Business Wire (press release) - Mar, 19 2018

Cannabis investor Privateer Holdings tacks on another $40 million in funding

- Nov, 4 2016

Other Companies

Learn More

Cresco Labs

Enhancing the lives of Illinois medical cannabis patients and inciting the progressive evolution of the medical cannabis industry.

$104MTotal Funding

Learn More

Mammoth Biosciences

Mammoth Biosciences is the CRISPR platform for diagnostics.

$0Total Funding

Learn More

Scanwell Health

Scanwell Health is an FDA-cleared urine testing application.

$120KTotal Funding

Learn More

Teleflex

Teleflex Incorporated is a diversified global company, distinguished by a significant presence in healthcare, with niche businesses that

$400MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Tilray or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.